PitchBook-2024年二季度医疗技术公共报表和估值指南（英）-2024

2024-07医疗健康9免费

📄 文件全名: 《PitchBook-2024年二季度医疗技术公共报表和估值指南（英）-2024-9页.pdf》
🎯 适合读者: 战略规划行业研究员
📊 核心数据: the remainder of the year compared to the years ahead. Consensus anticipates EPS growth from -3% up to 9% for the various
expect double-digit EPS growth across the board and EPS growth above 15% for both the diagnostics and consumer health
performing medtech stocks in the quarter, with gains of 18.4% and 17.8%, respectively. After initial market panic in 2023 about the
Exact Sciences, and Eurofins all declining more than 20%. Illumina’s shares remain under pressure from the forced divestiture of
3.9% and 8.3%, respectively, indicating that investors have been recently rotating away from medtech and toward other sectors.
🏷️ 核心议题: #医疗

📦 本报告属于月份合集

购买后将获得「2024 年 7 月报告合集」 · 共 3953 份报告打包下载链接

点击获取云盘下载链接

报告摘要

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Vice President, Institutional Research

❓ 常见问题

《PitchBook-2024年二季度医疗技术公共报表和估值指南（英）-2024》主要包含哪些内容?

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Vice President, Institutional Research核心数据:the remainder of the year compared to the years ahead. Consensus anticipates EPS growth from -3% up to 9% for the various;expect double-digit EPS growth across the board and EPS growth above 15% for both the diagnostics and consumer health;performing medtech stocks in the quarter, with gains of 18.4% and 17.8%, respectively. After initial market panic in 2023 about the。

这份报告覆盖哪一年、篇幅多大?

覆盖 2024 年,全文约 9。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合战略规划、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了医疗等议题。